Sanofi Takes $18.5B Bid To Genzyme Shareholders
Sanofi-Aventis SA on Monday took an $18.5 billion bid for Genzyme Corp. directly to the biotech company's shareholders after being rebuffed by the board, offering $69 per share as long as...To view the full article, register now.
Already a subscriber? Click here to view full article